Growth arrest and DNA damage-inducible protein 34 (GADD34) contributes to cerebral ischemic injury and can be detected in plasma exosomes

Neurosci Lett. 2021 Jul 27:758:136004. doi: 10.1016/j.neulet.2021.136004. Epub 2021 Jun 8.

Abstract

Growth arrest and DNA damage-inducible protein 34 (GADD34), one of the key effectors of negative feedback loops, is induced by stress and subsequently attempts to restore homeostasis. It plays a critical role in response to DNA damage and endoplasmic reticulum stress. GADD34 has opposing effects on different stimulus-induced cell apoptosis events in many nervous system diseases, but its role in ischemic stroke is unclear. In this study, we evaluated the role of GADD34 and its distribution in a rat cerebral ischemic model. The results showed that GADD34 was increased in the cortex and contributed to brain injury in ischemic rats. Furthermore, treatment with a GADD34 inhibitor reduced the infarct volume, improved functional outcomes, and inhibited neuronal apoptosis in the cortical penumbra after ischemia. The role of GADD34 in ischemic stroke was associated with the dephosphorylation of eukaryotic translation initiation factor 2α (eIF2α) and phosphorylation of p53. In addition, the GADD34 level was increased in plasma exosomes of cerebral ischemic rats. These findings indicate that GADD34 could be a potential therapeutic target and biomarker for ischemic stroke.

Keywords: Biomarker; GADD34; Ischemic stroke; Plasma exosomes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Differentiation / blood
  • Antigens, Differentiation / metabolism*
  • Biomarkers / blood
  • Biomarkers / metabolism
  • Cinnamates / pharmacology*
  • Cinnamates / therapeutic use
  • Disease Models, Animal
  • Eukaryotic Initiation Factor-2 / blood
  • Eukaryotic Initiation Factor-2 / metabolism
  • Exosomes / metabolism
  • Humans
  • Infarction, Middle Cerebral Artery / blood
  • Infarction, Middle Cerebral Artery / complications
  • Infarction, Middle Cerebral Artery / diagnosis*
  • Infarction, Middle Cerebral Artery / drug therapy
  • Male
  • Phosphorylation / drug effects
  • Proto-Oncogene Proteins / antagonists & inhibitors
  • Proto-Oncogene Proteins / blood
  • Proto-Oncogene Proteins / metabolism*
  • Rats
  • Reperfusion Injury / etiology
  • Reperfusion Injury / prevention & control*
  • Thiourea / analogs & derivatives*
  • Thiourea / pharmacology
  • Thiourea / therapeutic use
  • Tumor Suppressor Protein p53 / blood
  • Tumor Suppressor Protein p53 / metabolism

Substances

  • Antigens, Differentiation
  • Biomarkers
  • Cinnamates
  • Eukaryotic Initiation Factor-2
  • Ppp1r15a protein, rat
  • Proto-Oncogene Proteins
  • Tp53 protein, rat
  • Tumor Suppressor Protein p53
  • salubrinal
  • Thiourea